Evidence map›Paper›PMID 31589872›Full record

ArticleGastroenterology2020

Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.

Jeffrey K Lee, Christopher D Jensen, Theodore R Levin, Chyke A Doubeni, Ann G Zauber, Jessica Chubak, Aruna S Kamineni, Joanne E Schottinger, Nirupa R Ghai, Natalia Udaltsova and 7 more

Erratum issuedOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. A Systematic Review and Meta-analysis of Convolutional Neural Network in the Diagnosis of Colorectal Polyps and Cancer.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Metabolic syndrome and risk of advanced colorectal adenomas in a screening population: Frequentist and Bayesian analyses.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Article
  8. Article
  9. Accounting for Endoscopic Screening in Colorectal Cancer Risk Models.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Jeffrey K LeeDepartment of Gastroenterology, Kaiser Permanente San Francisco, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California. Electronic address: jeffrey.k.lee@kp.org.
Christopher D JensenDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Theodore R LevinDivision of Research, Kaiser Permanente Northern California, Oakland, California; Department of Gastroenterology, Kaiser Permanente Walnut Creek, Walnut Creek, California.
Chyke A DoubeniDepartment of Family Medicine, and the Center for Health Equity and Community Engagement Research, Mayo Clinic, Rochester, Minnesota.
Ann G ZauberDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Jessica ChubakKaiser Permanente Washington Health Research Institute, Seattle, Washington; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
Aruna S KamineniKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Joanne E SchottingerDepartment of Quality and Clinical Analysis, Kaiser Permanente Southern California, Pasadena, California.
Nirupa R GhaiDepartment of Regional Clinical Effectiveness, Kaiser Permanente Southern California, Pasadena, California.
Natalia UdaltsovaDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Wei K ZhaoDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Bruce H FiremanDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Charles P QuesenberryDivision of Research, Kaiser Permanente Northern California, Oakland, California.
E John OravDepartment of Biostatistics, Harvard University T.H. Chan School of Public Health, Boston, Massachusetts.
Celette S SkinnerDepartment of Population and Data Sciences and the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Ethan A HalmDepartment of Population and Data Sciences and the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Douglas A CorleyDepartment of Gastroenterology, Kaiser Permanente San Francisco, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California.
Kaiser Permanente · USKaiser Permanente Washington Health Research Institute · USThe University of Texas Southwestern Medical Center · USHarvard University · USMayo Clinic in Florida · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)UM1CA222035 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA, CORLEY, DOUGLAS ALLEN · 2018 to 2023
$15.6M
Optimizing the use of colonoscopy for CRC screening in a large community-basedU54CA163262 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN, DOUBENI, CHYKE ABADAMA · 2011 to 2017
$9.6M
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs. FITR01CA213645 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CORLEY, DOUGLAS ALLEN, DOUBENI, CHYKE ABADAMA · 2017 to 2021
$3.2M
Optimizing long-term post-polypectomy surveillance for colorectal cancer prevention using a prediction rule developed from a large, community-based cohortK07CA212057 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, JEFFREY KUANG ZOU · 2016 to 2020
$869k
NCI NIH HHS K07 CA212057NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA213645NCI NIH HHS U54 CA163262NCI NIH HHS UM1 CA222035
6 · The paper itself

Abstract

BACKGROUND &

aimsThe long-term risks of colorectal cancer (CRC) and CRC-related death following adenoma removal are uncertain. Data are needed to inform evidence-based surveillance guidelines, which vary in follow-up recommendations for some polyp types. Using data from a large, community-based integrated health care setting, we examined the risks of CRC and related death by baseline colonoscopy adenoma findings.

methodsParticipants at 21 medical centers underwent baseline colonoscopies from 2004 through 2010; findings were categorized as no-adenoma, low-risk adenoma, or high-risk adenoma. Participants were followed until the earliest of CRC diagnosis, death, health plan disenrollment, or December 31, 2017. Risks of CRC and related deaths among the high- and low-risk adenoma groups were compared with the no-adenoma group using Cox regression adjusting for confounders.

resultsAmong 186,046 patients, 64,422 met eligibility criteria (54.3% female; mean age, 61.6 ± 7.1 years; median follow-up time, 8.1 years from the baseline colonoscopy). Compared with the no-adenoma group (45,881 patients), the high-risk adenoma group (7563 patients) had a higher risk of CRC (hazard ratio [HR] 2.61; 95% confidence interval [CI] 1.87-3.63) and related death (HR 3.94; 95% CI 1.90-6.56), whereas the low-risk adenoma group (10,978 patients) did not have a significant increase in risk of CRC (HR 1.29; 95% CI 0.89-1.88) or related death (HR 0.65; 95% CI 0.19-2.18).

conclusionsWith up to 14 years of follow-up, high-risk adenomas were associated with an increased risk of CRC and related death, supporting early colonoscopy surveillance. Low-risk adenomas were not associated with a significantly increased risk of CRC or related deaths. These results can inform current surveillance guidelines for high- and low-risk adenomas.

Indexed as

AdenomaAgedCaliforniaColonoscopyColorectal NeoplasmsEarly Detection of CancerEvidence-Based MedicineFemaleFollow-Up StudiesHumansMaleMedical History TakingMiddle AgedPractice Guidelines as TopicProportional Hazards ModelsRetrospective StudiesAdenomaColonoscopyColorectal CancerPolyp

Identifiers

PMID31589872
PMCPMC7083250
OpenAlexW2977423544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.